Bioactive Flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers - Implications for Parkinson’s Disease

Flavonoids are known to trigger the intrinsic genetic adaptive programs to hypoxic or oxidative stress via estrogen receptor engagement or upstream kinase activation. To reveal specific structural requirements for direct stabilization of the transcription factors responsible for triggering the antihypoxic and antioxidant programs, we studied flavones, isoflavones and catechols including dihydroxybenzoate, didox, levodopa, and nordihydroguaiaretic acid (NDGA), using novel luciferase-based reporters specific for the first step in HIF1 or Nrf2 protein stabilization. Distinct structural requirements for either transcription factor stabilization have been found: as expected, these requirements for activation of HIF ODD-luc reporter correlate with in silico binding to HIF prolyl hydroxylase. By contrast, stabilization of Nrf2 requires the presence of 3,4-dihydroxy- (catechol) groups. Thus, only some but not all flavonoids are direct activators of the hypoxic and antioxidant genetic programs. NDGA from the Creosote bush resembles the best flavonoids in their ability to directly stabilize HIF1 and Nrf2 and is superior with respect to LOX inhibition thus favoring this compound over others. Given much higher bioavailability and stability of NDGA than any flavonoid, NDGA has been tested in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-animal model of Parkinson’s Disease and demonstrated neuroprotective effects.

[1]  G. Semenza,et al.  Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1* , 1996, The Journal of Biological Chemistry.

[2]  Joshua D Deschamps,et al.  Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases. , 2006, Bioorganic & medicinal chemistry.

[3]  I. Shureiqi,et al.  15-LOX-1 suppression of hypoxia-induced metastatic phenotype and HIF-1α expression in human colon cancer cells , 2014, Cancer medicine.

[4]  Y. Kan,et al.  Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte , 2009, Proceedings of the National Academy of Sciences.

[5]  Mark Hannink,et al.  Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex , 2004, Molecular and Cellular Biology.

[6]  G. Semenza,et al.  Selective Inhibition of Hypoxia-Inducible Factor (HIF) Prolyl-Hydroxylase 1 Mediates Neuroprotection against Normoxic Oxidative Death via HIF- and CREB-Independent Pathways , 2009, The Journal of Neuroscience.

[7]  D. Nie,et al.  12-Lipoxygenase and the regulation of hypoxia-inducible factor in prostate cancer cells. , 2010, Experimental cell research.

[8]  C. Sen,et al.  Neuroprotective Properties of the Natural Vitamin E &agr;-Tocotrienol , 2005, Stroke.

[9]  N. Moroz,et al.  Utilization of an in vivo reporter for high throughput identification of branched small molecule regulators of hypoxic adaptation. , 2010, Chemistry & biology.

[10]  J. Corton,et al.  Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.

[11]  W. Berkel,et al.  Pro-oxidant activity of flavonoids induces EpRE-mediated gene expression. , 2006, Chemical research in toxicology.

[12]  S. Kulling,et al.  Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. , 2006, Journal of agricultural and food chemistry.

[13]  José M. Morachis,et al.  Kinetic characterization and identification of a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 using a time-resolved fluorescence resonance energy transfer-based assay technology. , 2009, Analytical biochemistry.

[14]  J. Corton,et al.  Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. , 1998, Endocrinology.

[15]  A. Ritzén,et al.  Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitors. , 2011, Pharmacological research.

[16]  S. Rapoport,et al.  A lipoxygenase in rabbit reticulocytes which attacks phospholipids and intact mitochondria , 1975, FEBS letters.

[17]  R. V. van Breemen,et al.  New metabolic pathways for flavanones catalyzed by rat liver microsomes. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[18]  K. Vafeiadou,et al.  The neuroprotective potential of flavonoids: a multiplicity of effects , 2008, Genes & Nutrition.

[19]  Yunjin Jung,et al.  Quercetin Activates an Angiogenic Pathway, Hypoxia Inducible Factor (HIF)-1-Vascular Endothelial Growth Factor, by Inhibiting HIF-Prolyl Hydroxylase: a Structural Analysis of Quercetin for Inhibiting HIF-Prolyl Hydroxylase , 2007, Molecular Pharmacology.

[20]  Victor A Kenyon,et al.  Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2. , 2007, Bioorganic & medicinal chemistry.

[21]  N. Abe,et al.  1,1-Diphenyl-2-picrylhydrazyl Radical-scavenging Compounds from Soybean Miso and Antiproliferative Activity of Isoflavones from Soybean Miso toward the Cancer Cell Lines , 2000, Bioscience, biotechnology, and biochemistry.

[22]  Masayuki Yamamoto,et al.  Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease. , 2013, Antioxidants & redox signaling.

[23]  Masayuki Yamamoto,et al.  Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2 , 2004, Molecular and Cellular Biology.

[24]  W. Kaelin,et al.  The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing. , 2005, Biochemical and biophysical research communications.

[25]  Y. M. Lee,et al.  Baicalein Induces Functional Hypoxia-Inducible Factor-1α and Angiogenesis , 2008, Molecular Pharmacology.

[26]  Emiri T. Mandeville,et al.  Inhibition of 12/15‐lipoxygenase as therapeutic strategy to treat stroke , 2013, Annals of neurology.

[27]  De-Xing Hou,et al.  Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modeling. , 2010, Antioxidants & redox signaling.

[28]  K. Sekiya,et al.  Selective inhibition of platelet lipoxygenase by baicalein. , 1982, Biochemical and biophysical research communications.

[29]  E. Lo,et al.  Proteasome inhibition protects HT22 neuronal cells from oxidative glutamate toxicity , 2005, Journal of neurochemistry.

[30]  Robert J. Williams,et al.  Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease. , 2012, Free radical biology & medicine.

[31]  Renee E Haskew-Layton,et al.  Development of Neh2-luciferase reporter and its application for high throughput screening and real-time monitoring of Nrf2 activators. , 2011, Chemistry & biology.

[32]  S. Niture,et al.  Nrf2:inrf2 (keap1) Signaling in Oxidative Stress , 2022 .

[33]  D. Wallace,et al.  Subcutaneous daidzein administration enhances recovery of skilled ladder rung walking performance following stroke in rats , 2013, Behavioural Brain Research.

[34]  P. Maher,et al.  A Role for 12-lipoxygenase in Nerve Cell Death Caused by Glutathione Depletion , 1997, Neuron.

[35]  P. Maher,et al.  Chemical modification of the multitarget neuroprotective compound fisetin. , 2012, Journal of medicinal chemistry.

[36]  J. D. Engel,et al.  Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. , 1999, Genes & development.

[37]  S. Karuppagounder,et al.  Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson’s disease in rats , 2013, Neuroscience.

[38]  P. Maher.  Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin , 2009, Genes & Nutrition.

[39]  W. Schaal,et al.  Development of a Fluorescent Intensity Assay Amenable for High-Throughput Screening for Determining 15-Lipoxygenase Activity , 2010, Journal of biomolecular screening.

[40]  A. Dinkova-Kostova,et al.  Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein. , 2005, Biochemistry.

[41]  A. I. Rojo,et al.  Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. , 2011, Antioxidants & redox signaling.

[42]  J. Harper,et al.  The Keap1-BTB Protein Is an Adaptor That Bridges Nrf2 to a Cul3-Based E3 Ligase: Oxidative Stress Sensing by a Cul3-Keap1 Ligase , 2004, Molecular and Cellular Biology.

[43]  Masayuki Yamamoto,et al.  Nrf2-Keap1 defines a physiologically important stress response mechanism. , 2004, Trends in molecular medicine.

[44]  K. Majamaa,et al.  Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase. , 1986, The Journal of biological chemistry.

[45]  Subramanian Rajagopalan,et al.  Regulation of ATP13A2 via PHD2-HIF1α Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's Disease , 2016, The Journal of Neuroscience.

[46]  K. Vafeiadou,et al.  Antioxidant and free radical scavenging activity of isoflavone metabolites , 2003, Xenobiotica; the fate of foreign compounds in biological systems.

[47]  A. Aras,et al.  Neuroprotective effects of daidzein on focal cerebral ischemia injury in rats , 2015, Neural regeneration research.

[48]  E. Bézard,et al.  Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration , 2012, Proceedings of the National Academy of Sciences.

[49]  K. Arai,et al.  Baicalein and 12/15-Lipoxygenase in the Ischemic Brain , 2006, Stroke.

[50]  G. Rotilio,et al.  Benefits from Dietary Polyphenols for Brain Aging and Alzheimer’s Disease , 2008, Neurochemical Research.